Acquisition Growth Sentec has expanded through acquisitions, notably Pulmo Tech in March 2025 and Percussionaire in 2022, indicating a strategic path to broaden respiratory care capabilities and market reach. This presents cross-selling opportunities for integrated respiratory monitoring and therapy solutions across newly combined product lines.

Global Reach With Swiss-American roots and a worldwide healthcare professional base, Sentec operates in a broad, international market for non-invasive respiratory monitoring and therapy. This suggests potential for enterprise deals with hospitals and clinics across multiple regions and for multi-country standardization projects.

Advanced Tech Stack Sentec leverages a modern tech ecosystem including HubSpot, Salesforce, GitLab, and GitHub Copilot, signaling readiness for scalable digital engagement, customer relationship management, and devops-enabled product updates. Opportunities exist to upsell enhanced analytics, remote monitoring solutions, and integration services.

Financial Signals Reported revenue range of 25 to 50 million USD indicates a mid-market profile with potential for upsell into higher-value respiratory monitoring platforms, adjunct devices, and service contracts as the company scales its acquisitions and product lines.

Sustainability & Partnerships Past collaborations in sustainability initiatives and partnerships at career events point to a value proposition around responsible manufacturing and eco-friendly programs. This opens doors for healthcare buyers prioritizing ESG criteria, and for partnerships with ecological certification bodies to support procurement decisions.